Giulia Galli

3.0k total citations
90 papers, 1.5k citations indexed

About

Giulia Galli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Giulia Galli has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 40 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Giulia Galli's work include Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (9 papers). Giulia Galli is often cited by papers focused on Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Treatments and Mutations (21 papers) and Cancer Genomics and Diagnostics (9 papers). Giulia Galli collaborates with scholars based in Italy, United States and France. Giulia Galli's co-authors include Filippo de Braud, Giuseppe Lo Russo, Marina Chiara Garassino, Claudia Proto, Diego Signorelli, Monica Ganzinelli, Roberto Ferrara, Rosamaria Lappano, Marcello Maggiolini and Nicoletta Zilembo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Giulia Galli

87 papers receiving 1.5k citations

Peers

Countries citing papers authored by Giulia Galli

Since Specialization

Citations

This map shows the geographic impact of Giulia Galli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Galli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Galli more than expected).

Fields of papers citing papers by Giulia Galli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Galli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Galli. The network helps show where Giulia Galli may publish in the future.

Co-authorship network of co-authors of Giulia Galli

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Galli. A scholar is included among the top collaborators of Giulia Galli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Galli. Giulia Galli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CT and MRI radiomic features of lung cancer (NSCLC): comparison and software consistency 2024 ·European Radiology Experimental ·Chandra Bortolotto, (unknown), (unknown), (unknown), (unknown), Ian Postuma, (unknown), Giulia Maria Stella, Giulia Galli, Manuel Mariani, Silvia Figini, (unknown), Andrea Riccardo Filippi, Olivia Maria Bottinelli, Lorenzo Preda	5
2	Clinical Trials of Cellular Therapies in Solid Tumors 2023 ·Cancers ·Simona Secondino, Costanza Canino, (unknown), (unknown), Giulia Galli, (unknown), Sabrina Basso, (unknown), (unknown), Patrizia Comoli, Paolo Pedrazzoli	7
3	Spermatocytic Tumor: A Review 2023 ·International Journal of Molecular Sciences ·Simona Secondino, Alessandra Viglio, Giuseppe Neri, Giulia Galli, (unknown), (unknown), Richard Naspro, Giovanni Rosti, Paolo Pedrazzoli	2
4	Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease 2023 ·Cancers ·(unknown), Francesco Agustoni, Giulia Galli, Chandra Bortolotto, (unknown), (unknown), (unknown), (unknown), (unknown), Gioacchino D’Ambrosio, Angelo Guido Corsico, Paolo Pedrazzoli, Giulia Maria Stella	0
5	SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis 2022 ·European Journal of Cancer ·Federica Giugliano, Paolo Andrea Zucali, Giulia Galli, Z. Ballatore, Chiara Corti, Pamela Trillo Aliaga, (unknown), (unknown), Giuseppe Curigliano, Fabio Conforti, Paola Queirolo, Rossana Berardi, Sara Manglaviti, (unknown), Matteo Perrino, (unknown), (unknown), Marina Chiara Garassino, Tommaso De Pas	3
6	Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 2021 ·Critical Reviews in Oncology/Hematology ·Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli, Nicoletta Zilembo, Filippo de Braud, Marina Chiara Garassino	5
7	Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors 2021 ·Journal of Personalized Medicine ·Mario Occhipinti, Marta Brambilla, Giulia Galli, Sara Manglaviti, (unknown), Arsela Prelaj, Roberto Ferrara, Alessandro De Toma, Claudia Proto, (unknown), Emma Zattarin, Giuseppe Lo Russo, Alain Gelibter, Maurizio Simmaco, Robert Preißner, Marina Chiara Garassino, Filippo de Braud, Paolo Marchetti	8
8	1278P Hyperprogressive disease (HPD) upon first-line PD-1/PD-L1 inhibitors (ICI) as single agent or in combination with platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients (pts) 2020 ·Annals of Oncology ·Roberto Ferrara, Francesco Facchinetti, Giuseppina Calareso, (unknown), Diego Signorelli, Claudia Proto, Arsela Prelaj, Charles Naltet, Pernelle Lavaud, (unknown), Giuseppe Viscardi, Giulia Galli, Alessandro De Toma, Antonia Martinetti, Fabrice Barlési, David Planchard, J.C. Soria, Marina Chiara Garassino, Benjamin Besse, Giuseppe Lo Russo	7
9	1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program 2020 ·Annals of Oncology ·Arsela Prelaj, (unknown), Claudia Proto, Giuseppe Lo Russo, Diego Signorelli, Roberto Ferrara, Giulia Galli, Alessandro De Toma, Giuseppe Viscardi, Marta Brambilla, Riccardo Lobefaro, Sara Manglaviti, Mario Occhipinti, (unknown), Rosaria Gallucci, (unknown), Nicoletta Zilembo, Francesca Gabriella Greco, Valter Torri, Marina Chiara Garassino	5
10	GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression 2019 ·Cells ·Maria Francesca Santolla, Adele Vivacqua, Rosamaria Lappano, Damiano Cosimo Rigiracciolo, Francesca Cirillo, Giulia Galli, Marianna Talia, Giuseppe Brunetti, Anna Miglietta, Antonino Belfiore, Marcello Maggiolini	49
11	The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells 2019 ·Cells ·Rosamaria Lappano, Christophe Mallet, Bruno Rizzuti, Fedora Grande, Giulia Galli, Cillian Byrne, Isabelle Broutin, (unknown), Alain Eschalier, Yves Jacquot, Marcello Maggiolini	25
12	Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer 2019 ·Lung Cancer ·Giulia Galli, Tiziana Triulzi, Claudia Proto, Diego Signorelli, Martina Imbimbo, M. Poggi, Giovanni Fucà, Monica Ganzinelli, Milena Vitali, Dario Palmieri, Anna Tessari, Filippo de Braud, Marina Chiara Garassino, Mario P. Colombo, Giuseppe Lo Russo	53
13	Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis 2019 ·Oncology Research and Treatment ·Giulia Galli, Stefano Cavalieri, Lorenza Di Guardo, Carolina Cimminiello, Federico Nichetti, Francesca Corti, (unknown), (unknown), C. Fallai, Filippo de Braud, Marco Platania, Michele Del Vecchio	19
14	miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 2018 ·Cells ·Adele Vivacqua, (unknown), Anna Miglietta, Damiano Cosimo Rigiracciolo, Francesca Cirillo, Giulia Galli, Marianna Talia, Maria Francesca Santolla, Rosamaria Lappano, Francesca Giordano, Maria Luisa Panno, Marcello Maggiolini	28
15	Complete remission in metastatic breast cancer: expecting the unexpected—results of a cross-sectional study 2017 ·Breast Cancer ·Giulia Galli, Anna Tessari, Luca Porcu, Giacomo Bregni, Biagio Paolini, Maria Luisa Carcangiu, Massimiliano Gennaro, Maria Carmen De Santis, Laura Lozza, Filippo de Braud, Serena Di Cosimo	2
16	Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC) 2017 ·Annals of Oncology ·Gabriella Mariani, Giulia Galli, Stefano Cavalieri, Pinuccia Valagussa, Giulia Bianchi, Giuseppe Capri, Sara Cresta, L. Ferrari, Silvia Damian, (unknown), Filippo de Braud, Angela Moliterni	1
17	Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging 2016 ·Annals of Oncology ·Stefano Cavalieri, Alessandra Raimondi, Daniele Morelli, Antonia Martinetti, Filippo de Braud, Francesco Agustoni, Katia Dotti, Giulia Galli, Claudio Vernieri, Giovanni Fucà, (unknown), Michele Prisciandaro, Federico Nichetti, (unknown), Giuseppe Lo Russo, Natalie Prinzi, Marina Chiara Garassino, Marco Platania	1
18	Breast cancer Ki67, tumor size and axillary nodes relationship: it's complicated 2016 ·Annals of Oncology ·Giacomo Bregni, E. Meneghini, Giulia Galli, Stefano Cavalieri, F. Di Salvo, H. Amash, Biagio Paolini, Filippo de Braud, Maria Carmen De Santis, Milena Sant, Serena Di Cosimo	1
19	Tokio Rationale and Protocol: A Phase II Study to Evaluate the Activity and Safety of Third-line Tyrosine Kinase Inhibitor after 2 Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell Carcinoma 2015 ·Tumori Journal ·Elena Verzoni, Paolo Grassi, (unknown), Giulia Galli, Andrea Necchi, Giuseppe Procopio	1
20	Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients 2014 ·Oncology ·Giuseppe Procopio, (unknown), Elena Verzoni, Roberto Iacovelli, Paolo Grassi, Giulia Galli, Filippo de Braud, (unknown), Roberto Salvioni	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact